Tenofovir cuts HIV infection risk in injection drug users

06/13/2013 | HealthDay News

Researchers tracked more than 2,400 injection drug users in Thailand and found that daily intake of the antiviral drug tenofovir was associated with an almost 49% lower risk of HIV infection. Patients who most closely adhered to the prescribed regimen benefited the most from tenofovir's protective effect. The findings were reported in The Lancet.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA